Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News Alert: US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

News You Need to Know Today
News Alert: US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk
Tuesday, April 13, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 

READ MORE >
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.
Share on Twitter Share on Facebook Share on Linkedin

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.
The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Preventing the most common complication after heart surgery | When bioprosthetic valves fail | Good news for Medtronic
PFA's dominance & other key EP trends | FDA approves next-gen mitral valve | Virtual nursing helps practices combat burnout
FDA's new device warning | How to implement AI-powered coronary plaque software | Key approvals for Abbott | IV fluids recalled
New SCAI president outlines focus into 2027 | DCBs have similar outcomes to DES | GLP-1s lower AFib
‘Father of modern cardiology’ dies at 96 | High-risk women missing out on care | Tirzepatide beneficial for TAVR & PCI patients
Week in Review: Cardiologist pay climbs 10% | Energy drinks & heart disease | CMS, FDA propose major change | Treating HFmrEF
Strokes after PFA | Hospital sues practice | FDA approves fast-acting drug for children | The cardiologist shortage continues

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …7
    • Page 8
    • Page 9
    • Page 10
    • Current page 11
    • Page 12
    • Page 13
    • Page 14
    • Page 15 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme